会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 103. 发明申请
    • Inhibition of Neovascularization by Cerium Oxide Nanoparticles
    • 通过氧化铈纳米颗粒抑制新血管形成
    • US20120093931A9
    • 2012-04-19
    • US12429650
    • 2009-04-24
    • James F. McGinnisLily L. WongXiaohong ZhouSudipta Seal
    • James F. McGinnisLily L. WongXiaohong ZhouSudipta Seal
    • A61K33/24A61P29/00A61P17/00A61P9/00A61P19/02A61P1/00A61K9/14A61P27/02
    • A61K9/14A61K33/24
    • The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by administration in vivo of nanoceria particles (cerium oxide nanoparticles) to the subject. The method of the invention is useful, for example, for reducing, treating, reversing or inhibiting neovascularization in ocular tissue such as the retina, macula or cornea; in skin; in synovial tissue; in intestinal tissue; or in bone. In addition, the method of the invention is useful for reducing or inhibiting neovascularization in a neoplasm (tumors), which can be benign or malignant and, where malignant, can be a metastatic neoplasm. As such, the invention provides compositions, which contain nanoceria particles and are useful for reducing, treating, reversing or inhibiting angiogenesis in a mammalian subject.
    • 本发明提供了通过在受试者体内施用纳米颗粒(氧化铈纳米颗粒)的体内,减少,逆转或抑制具有涉及新血管形成的病理状况的哺乳动物受试者的组织中的新生血管形成的方法。 本发明的方法例如用于减少,治疗,逆转或抑制眼组织如视网膜,黄斑或角膜中的新生血管形成; 在皮肤上 在滑膜组织中 在肠组织中 或在骨头。 此外,本发明的方法可用于减少或抑制肿瘤(肿瘤)中的新生血管形成,其可以是良性或恶性的,并且恶性肿瘤可以是转移性肿瘤。 因此,本发明提供了含有纳米颗粒并且可用于在哺乳动物受试者中减少,治疗,逆转或抑制血管生成的组合物。